Identification of distinct surface-expressed and intracellular CXC- chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 1044-1052

  Ludwig, Andreas ^a   Ehlert, Jan E ^a   Flad, Hans Dieter ^a   Brandt, Ernst ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; INTERLEUKIN 8;

ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; DEGLYCOSYLATION; GLYCOSYLATION; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034662235     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.1044     Document Type: Article

References (35)

1. Rollins, B. J. 1997. Chemokines. Blood 90:909.
2. Brandt, E., M. Ernst. H. Loppnow, and H.-D. Flad. 1989. Characterization of a platelet derived factor modulating phagocyte functions and cooperating with interleukin 1. Lymphokine Res. 8:281.
3. Walz, A., and M. Baggiolini. 1989. A novel cleavage product of β-thromboglobulin formed in cultures of stimulated mononuclear cells activates neutrophils. Biochem. Biophys. Res. Commun. 159:969.
4. Holmes, W. E., J. Lee, W.-J. Kuang, C. C. Rice, and W. I. Wood. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253:1278.
5. Murphy, P. M., and H. L. Tiffany. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280.
6. Ahuja, S. K., and P. M. Murphy. 1996. The CXC chemokines growth-regulated oncogene (GRO)α, GROβ, GRO-γ, neutrophil-activating peptide-2, and epithelial cell-derived neulrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J. Biol. Chem. 271:20545.
7. Ludwig, A., F. Petersen, S. Zahn, O. Götze, J. M. Schröder, H. D. Flad, and E. Brandt, 1997. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90:4588.
8. Petersen, F., H. D. Flad, and E. Brandt. 1994. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways: discrepancies in binding affinities, receptor densities, and biologic effects. J. Immunol. 152:2467.
9. Samanta, A. K., J. J. Oppenheim, and K. Matsushima. 1990. Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J. Biol Chem. 265:183.
10. Chuntharapai, A., and K. J. Kim. 1995. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J. Immunol. 155:2587.
11. Sabroe, I., T. J. Williams, C. A. Hebert, and P. D. Collins. 1997. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J. Immunol. 158:1361.
12. Yang, W., D. Wang, and A. Richmond. 1999. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction. J. Biol. Chem. 274:11328.
13. Khandaker, M. H., L. Xu, R. Rahimpour, G. Mitchell, M. E. DeVries, J. G. Pickering, S. K. Singhal, R. D. Feldman, and D. J. Kelvin. 1998. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J. Immunol. 161:1930.
14. Asagoe, K., K. Yamamoto, A. Takahashi, K. Suzuki, A. Maeda, M. Nohgawa, N. Harakawa, K. Takano, N. Mukaida, K. Matsushima, et al. 1998. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-α. J. Immunol. 160:4518.
15. Khandaker, M. H., G. Mitchell, L. Xu, J. D. Andrews, R. Singh, H. Leung, J. Madrenas, S. S. Ferguson, R. D. Feldman, and D. J. Kelvin. 1999. Metalloproteinases are involved in lipopolysaccharide-and tumor necrosis factor-α-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93:2173.
16. Rademacher, T. W., and R. A. Dwek. 1989. The role of oligosaccharides in modifying protein function. Ciba Found. Symp. 145:241.
17. Paulson, J. C. 1989. Glycoproteins: what are the sugar chains for? Trends. Biochem. Sci. 14:272.
18. Innamorati, G., H. Sadeghi, and M. Bimbaumer. 1996. A fully active nonglycosylated V2 vasopressin receptor. Mol. Pharmacol. 50:467.
19. Bisello, A., Z. Greenberg, V. Behar, M. Rosenblatt, L. J. Suva, and M. Chorev. 1996. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor. Biochemistry 35:15890.
20. Ray, K., P. Clapp, P. K. Goldsmith, and A. M. Spiegel. 1998. Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction. J. Biol. Chem. 273: 34558.
21. Couvineau, A., C. Fahre, P. Gaudin, J. J. Maroet, and M. Laburthe. 1996. Mulagenesis of N-glycosylation sites in the human vasointestinal peptide 1 receptor: evidence that asparagine 58 and 69 is crucial for correct delivery of the receptor to plasma membrane. Biochemistry 35:1745.
22. Rands, E., M. R. Candelore, A. H. Cheung, W. S. Hill, D. Catherine, D. Strader, and R. A. Dixon. 1990. Mutational analysis of β-adrenergic receptor glycosylation. J. Biol. Chem. 265:10759.
23. Ben-Baruch, A., K. Bengali, K. Tani, L. Xu, J. J. Oppenheim, and J. M. Wang. 1997. IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B. Cytokine 9:37.
24. Tikhonov, I. I., I. K. Fomin, T. M. Doroshenko, I. V. Chalyi, and N. N. Voitenok. 1996. Expression of cDNA for human interleukin-8 type one receptor in BALB 3T3 fibroblasts and characteristics of products of expression. Mol. Biol. (Mosk.) 30:1014.
25. Brandt, E., J. Van Damme, and H.-D. Flad. 1991. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 3:311.
26. Tarentino, A. L., C. M. Gomez, and T. H. Plummer. 1995. Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F. Biochemistry 24:4665.
27. Grob, P. M., E. David, T. C. Warren, R. P. DeLeon, P. R. Farina, and C. A. Homon. 1990. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J. Biol. Chem. 265:8311.
28. Manna, S. K., and A. K. Samanta. 1995. Upregulation of interteukin-8 receptor in human polymorphonuclear neutrophils by formyl peptide and lipopolysaccharide. FEBS Lett. 367:117.
29. Schumacher, C., I. Clark-Lewis, M. Baggiolini, and B. Moser. 1992. High-and low-affinity binding of groα and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc. Natl. Acad. Sci. USA 89:10542.
30. Besemer, J., W. Schnitzel, U. Monschein, and B. Ryffel. 1993. Cross-linking of human neutrophil surface proteins to iodinated interleukin 8 or neutrophil activating peptide-2 results in at least four separable proteins. Cytokine 5:512.
31. Morohashi, H., T. Miyawaki, H. Nomura, K. Kuno, S. Murakami, K. Matsushima, and N. Mukaida. 1995. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J. Leukocyte Biol. 57:180.
32. Landolt-Marticorena, C., and R. A. Reithmeier. 1994. Asparagine-linked oligosaccharides are localized to single extracytosolic segments in multi-span membrane glycoproteins. Biochem. J. 302:253.
33. Opdenakker, G., P. M. Rudd, C. P. Ponting, and R. A. Dwek. 1993. Concepts and principles of glycobiology. FASEB J. 7:1330.
34. Ray, K., G. F. Fan, P. K. Goldsmith, and A. M. Spiegel. 1997. The carboxyl terminus of the human calcium receptor: requirements for cell-surface expression and signal transduction. J. Biol. Chem. 272:31355.
35. Sengelov, H., F. Boulay, L. Kjeldsen, and N. Borregaard. 1994. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem. J. 299:473.